A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clini...
News from Institute of Cancer and Blood Diseases
Dr. Mollà: The incorporation of precision medicine allows us to advance in the prevention, diagnosis and treatment of cancer patients
We speak to Dr. Mertixell Mollà, head of the Radiation Oncology Service and coordinator of the Hospital Clínic Cancer Technical Committee, about th...
Developed the first genomic test for personalized HER2+ breast cancer treatments
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Liquid biopsy: the most sensitive and least invasive cancer analysis technique
A study conducted at Hospital Clínic analysed the genetic profile of more than 300 patients with solid tumours using a liquid biopsy blood test, re...
Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood ca...
The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organizati...
The Hospital Clínic launches an immunotherapy home infusion programme
The Hospital Clínic Medical Oncology Service, led by Dr. Aleix Prat, has launched a home infusion programme for solid organ cancer patients and imm...
Seven specialities at the Hospital Clínic among the best in the world, according to Newsweek’s World's Best Specialized Hospitals 2022
Cardiology, cardiac surgery, orthopaedic surgery and traumatology, gastroenterology, endocrinology and nutrition, neurology and medical oncology ar...
Launch of a pioneering clinical trial to validate the efficacy of immunotherapy in 29 types of tumour
The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 2...
A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity...